Epstein-Barr Virus EBV Reactivation in COVID

Some folks with mild acute COVID are developing more long-term reactivation of EBV as measured by antibodies in the blood elevated antibodies to this virus. So it looks like this could be this could be an explanation for why there is a subgroup of individuals irrespective of whether they had severe infection to start with or mild infection. It's something we're seeing in relation to the role of Epstein-Barr virus in multiple sclerosis where you also see auto immunity and you also see incidentally increased risk in women.